HighTower Advisors »

Protagonist Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $487k 11k 44.73
2024-06-30 $828k 24k 34.81

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl A (GOOGL)
Sharkninja Com Shs (SN)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for HighTower Advisors

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
Johnson & Johnson
BVF
Pacer Advisors
Leucadia National Corporation
T. Rowe Price Associates
Geode Capital Management
Perceptive Advisors
ADAR1 Capital Management
Wellington Management Company
American Century Companies

View all funds holding Protagonist Therapeutics